Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?
The Food and Drug Administration announced last week that it's investigating reports of secondary cancers in patients who received CAR T-cell therapy, one of a suite of immunotherapies that have revolutionized cancer care ...
Dec 8, 2023
0
0
